Mike
I am playing the Devil's advocate. My criticism is in the best interests.
PPS growth would not have given us money for operations. It would have only increased market cap and possibly blind-sided us.
Spending on R&D is fine but one has to be within means and that should not justify being left short of funds. In fact the only reason why the pps has not shown healthy growth, besides manipulation, is that quarter on quarter, the results have not truly impressed. Had that not been the case, it would have been difficult to keep this down. Everything else is fine with this company except the expense control.
I want this to succeed as much as you do brother but we have not seen that happen so far.